Invesco (NYSE:IVZ) saw its price target increased by TD Cowen analysts, signaling confidence in the investment management firm's future performance. The firm's price target was raised to $22.00, up ...

TD Cowen analysts increased the price target for Synchrony Financial (NYSE:SYF) shares to $80.00, up from the previous $75.00, while reiterating a Buy rating. The adjustment follows Synchrony ...

Tyler Van Buren, an analyst from TD Cowen, maintained the Buy rating on Gilead Sciences (GILD – Research Report). The associated price target ...

TD Cowen upgraded Roper Technologies (ROP) to Buy from Hold with a price target of $615, up from $535. Given macroeconomic and policy ...

This month, in the Wasatch Mountains of Utah, the Sundance Film Festival is once again providing a showcase for independent ...

Then, at 9 p.m., Trump pulled one over on the partygoers.

Odyssey Therapeutics is a promising biotech firm poised for IPO success with a focus on inflammatory and autoimmune diseases ...

Texas would join at least a dozen states already have universal voucher programs. Many more states offer limited school ...

Tuesday, TD Cowen reaffirmed its Buy rating and $285.00 price target on ICON plc shares (NASDAQ:ICLR), following the company's financial guidance. According to InvestingPro analysis, ICON ...

In a complaint filed Tuesday, the Consumer Financial Protection Bureau took aim at Capital ... Analyst commentary from TD Cowen on Tuesday noted that the CFPB still brought enforcement actions under ...

Tuesday, analysts at TD Cowen began coverage on CG Oncology (NASDAQ ... InvestingPro analysis reveals the company maintains a strong financial position with more cash than debt on its balance sheet.

After a disappointing showing by Easton Cowan and Team Canada at the World Junior Championship, Cowan may be available for trade. Team Canada was once again eliminated in the quarterfinals ...